BioLaurus conducts in-vivo preclinical molecular imaging research across oncology, cardiovascular, CNS, immunology, and metabolic disease — using a comprehensive multi-modality platform.
Tumor efficacy studies, CAR-T cell tracking, immune-oncology imaging assays, and radiopharmaceutical biodistribution across murine and NHP cancer models.
In vivo organ function imaging for complex safety pharmacology questions arising from Phase II and III clinical trials — cardiac, hepatic, renal, and CNS.
Multi-compartmental drug pharmacokinetics, mechanism-of-action imaging, and platelet sequestration PK with cyclotron-produced radiotracers.
Mu-opioid receptor occupancy, CNS drug PK, and blood-brain barrier penetration imaging including non-human primate brain studies.
Gold-standard for quantitative in-vivo molecular imaging. C-11, F-18, Zr-89, Lu-177, Y-90 radiotracer capabilities through our cyclotron partner network.
Multi-isotope simultaneous imaging for biodistribution, organ function, and pharmacokinetic studies across rodents to NHPs.
High-resolution anatomical and functional MRI for soft tissue characterization, tumor volume measurement, and perfusion studies.
Fluorescence and bioluminescence imaging for cell tracking, gene expression studies, and longitudinal tumor monitoring in small animals.
Real-time cardiac function, vascular imaging, tumor characterization, and guided injections across rodent and large animal models.
Representative active imaging programs across therapeutic areas and development stages.
Contact BioLaurus to propose a collaboration, request a study RFQ, or discuss study design for your drug program.
Founded · San Diego, CA 92106
Contract Research Organization
Accredited Vivarium Network
Multi-Species Imaging Capability